Oguz M, Demirci M. Comment on “Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis”. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2025;21(2):289-290. doi:10.5114/aic.2025.151709.
APA
Oguz, M., & Demirci, M. (2025). Comment on “Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis”. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 21(2), 289-290. https://doi.org/10.5114/aic.2025.151709
Chicago
Oguz, Mustafa, and Murat Demirci. 2025. "Comment on “Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis”". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 21 (2): 289-290. doi:10.5114/aic.2025.151709.
Harvard
Oguz, M., and Demirci, M. (2025). Comment on “Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis”. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 21(2), pp.289-290. https://doi.org/10.5114/aic.2025.151709
MLA
Oguz, Mustafa et al. "Comment on “Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis”." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 21, no. 2, 2025, pp. 289-290. doi:10.5114/aic.2025.151709.
Vancouver
Oguz M, Demirci M. Comment on “Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis”. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2025;21(2):289-290. doi:10.5114/aic.2025.151709.
